Our Pricing

The Science Behind How Sildenafil Works for ED

Understanding how sildenafil works for erectile dysfunction helps patients make informed treatment decisions. Sildenafil, the active ingredient in Viagra, functions as a selective phosphodiesterase type 5 (PDE5) inhibitor that enhances natural erectile responses by improving blood flow to penile tissue [1]. At Cured Pharmacy, our UK-registered clinical team provides evidence-based guidance alongside genuine sildenafil from £0.45, subject to prescriber approval.

The Molecular Mechanism: How Sildenafil Works at Cellular Level

Sildenafil's therapeutic action begins when sexual stimulation triggers the release of nitric oxide (NO) in the corpus cavernosum of the penis [1]. This nitric oxide activates an enzyme called guanylate cyclase, which increases levels of cyclic guanosine monophosphate (cGMP) — a crucial chemical messenger that relaxes smooth muscle cells in penile blood vessels.

Under normal physiological conditions, the enzyme phosphodiesterase type 5 (PDE5) breaks down cGMP, limiting the duration of smooth muscle relaxation [2]. Sildenafil selectively inhibits PDE5, preventing cGMP degradation and allowing sustained smooth muscle relaxation. This results in increased blood flow into the penile corpora cavernosa, facilitating erection in response to sexual stimulation.

Clinical trials have demonstrated that sildenafil exhibits dose-dependent efficacy, with approximately 82% of men achieving improved erections at the 100mg dose compared to 25% with placebo [3]. The medication does not cause spontaneous erections — sexual arousal remains necessary to initiate the nitric oxide cascade that sildenafil then amplifies.

Pharmacokinetics: Absorption, Distribution, and Duration

After oral administration, sildenafil is rapidly absorbed from the gastrointestinal tract, reaching peak plasma concentrations within 30 to 120 minutes in fasted individuals [1]. High-fat meals can delay absorption by approximately 60 minutes and reduce peak concentration by 29%, which is why patients are often advised to take sildenafil on an empty stomach for optimal efficacy.

The medication has a plasma half-life of approximately 3 to 5 hours in most patients, though this extends in elderly individuals and those with hepatic or severe renal impairment [2]. Sildenafil is metabolised primarily by hepatic cytochrome P450 enzymes (CYP3A4 and CYP2C9), producing an active metabolite that contributes approximately 20% of sildenafil's pharmacological activity.

Clinical effectiveness typically lasts 4 to 6 hours, during which time patients may achieve multiple erections in response to sexual stimulation [3]. This duration makes sildenafil suitable for on-demand use, distinguishing it from daily-dose alternatives.

Factors Affecting Sildenafil Absorption

Individual variation in absorption rates can influence onset time and efficacy. Alcohol consumption, particularly in excess, may impair erectile function independently and reduce sildenafil's effectiveness [4]. Certain medications, including CYP3A4 inhibitors like erythromycin and ketoconazole, can increase sildenafil plasma levels, necessitating dose adjustments under prescriber guidance.

Sildenafil Selectivity and Why PDE5 Inhibition Matters

The human body contains multiple phosphodiesterase enzyme families (PDE1 through PDE11), each with distinct tissue distributions and physiological roles [2]. Sildenafil's therapeutic profile depends on its selectivity for PDE5 over other isoforms — it is approximately 10-fold more selective for PDE5 than PDE6, and over 80-fold more selective than PDE1.

PDE5 is predominantly expressed in the corpus cavernosum, but also exists in lower concentrations in vascular smooth muscle, platelets, and the retina [1]. This distribution explains both sildenafil's primary therapeutic effect and its recognised side effects. Mild cross-reactivity with PDE6, which is present in retinal photoreceptors, accounts for the transient visual disturbances (blue-tinged vision) reported by approximately 3% of users at higher doses [3].

The selectivity for PDE5 over PDE3 — the predominant phosphodiesterase in cardiac tissue — provides an important safety margin. Unlike non-selective PDE inhibitors, sildenafil does not significantly affect cardiac contractility at therapeutic doses, contributing to its established cardiovascular safety profile in appropriately selected patients [4].

Clinical Efficacy: What the Evidence Shows

Systematic reviews of randomised controlled trials demonstrate that sildenafil significantly improves all domains of erectile function across diverse patient populations [3]. In men with organic erectile dysfunction, success rates (defined as achieving erections sufficient for intercourse) range from 43% to 82% depending on underlying aetiology and dose administered.

The medication shows particular efficacy in psychogenic erectile dysfunction, where success rates approach 84% at optimal dosing [1]. Even in challenging populations — including men with diabetes mellitus, post-prostatectomy patients, and those with cardiovascular disease — sildenafil produces statistically significant improvements compared to placebo, though absolute response rates vary by severity of vascular or neurological impairment [4].

Long-term studies extending beyond 12 months confirm sustained efficacy without development of pharmacological tolerance [2]. Patient-reported outcomes consistently demonstrate improvements not only in erectile function scores but also in overall sexual satisfaction, confidence, and relationship quality.

Response Predictors and Optimising Outcomes

Clinical experience indicates that adequate trial of sildenafil requires testing on at least 4 to 6 separate occasions, as initial attempts may be affected by performance anxiety or suboptimal dosing [3]. Prescribers may titrate doses from 25mg to 100mg based on individual efficacy and tolerability, with higher doses generally producing greater response rates in men with more severe erectile dysfunction.

How Sildenafil Works Compared to Tadalafil and Other PDE5 Inhibitors

While all PDE5 inhibitors share the same fundamental mechanism — selective inhibition of phosphodiesterase type 5 — they differ in pharmacokinetic profiles and duration of action [2]. Sildenafil's 4 to 6 hour window of effectiveness contrasts with tadalafil's extended 36-hour duration, offering different advantages depending on patient preference and sexual activity patterns.

Tadalafil exhibits slightly greater selectivity for PDE5 over PDE6, potentially reducing visual side effects, whilst sildenafil's faster onset (often within 30 minutes) may suit patients preferring shorter planning windows [1]. Both medications demonstrate comparable efficacy in head-to-head trials, with patient choice often depending on lifestyle factors and side effect profiles rather than superior effectiveness.

At Cured Pharmacy, patients can access both sildenafil from £0.45 and tadalafil from £0.45 following free online consultation with UK prescribers. Our clinical team assesses medical history, concurrent medications, and individual preferences to recommend the most appropriate PDE5 inhibitor for each patient's circumstances.

Safety Considerations and How Sildenafil Works With Other Medications

Sildenafil's mechanism of action creates important drug interactions that UK prescribers carefully evaluate during clinical assessment [4]. The most critical contraindication involves concurrent nitrate use — medications like glyceryl trinitrate prescribed for angina. Because both nitrates and sildenafil increase cGMP levels through different pathways, combined use can cause severe, potentially life-threatening hypotension.

Alpha-blockers used for benign prostatic hyperplasia or hypertension also warrant caution, as both drug classes reduce blood pressure through smooth muscle relaxation [2]. Prescribers typically recommend starting with lower sildenafil doses (25mg) in patients stabilised on alpha-blocker therapy, with careful monitoring for symptomatic hypotension.

Common side effects — headache (16%), flushing (10%), dyspepsia (7%), and nasal congestion (4%) — relate directly to PDE5 inhibition in non-genital vascular beds and are generally mild and transient [3]. Serious cardiovascular events are rare and typically occur in men with pre-existing cardiovascular risk factors, emphasising the importance of thorough medical screening before prescribing.

All sildenafil prescriptions at Cured Pharmacy require completion of a clinical assessment by UK-registered prescribers who evaluate cardiovascular health, medication interactions, and contraindications. This ensures safe, appropriate use tailored to individual medical profiles.

When to Seek Medical Review

Patients should seek immediate medical attention if they experience priapism (erection lasting over 4 hours), sudden vision or hearing loss, or chest pain during sexual activity [4]. These rare but serious events require urgent evaluation. Our superintendent pharmacist, Tarun Kumar (GPhC 2233073), and clinical team remain available for guidance on (+44) 116 4646009.

Scientific References

1. Eardley, I., et al. (2010). Pharmacotherapy for erectile dysfunction. Journal of Sexual Medicine, 7(1 Pt 2), 524–540. https://doi.org/10.1111/j.1743-6109.2009.01627.x
2. Corbin, J. D., & Francis, S. H. (2002). Pharmacology of phosphodiesterase-5 inhibitors. International Journal of Clinical Practice, 56(6), 453–459.
3. Goldstein, I., et al. (1998). Oral sildenafil in the treatment of erectile dysfunction. New England Journal of Medicine, 338(20), 1397–1404. https://doi.org/10.1056/NEJM199805143382001
4. Jackson, G., et al. (2006). Cardiovascular aspects of sexual medicine. Journal of Sexual Medicine, 3(2), 200–209. https://doi.org/10.1111/j.1743-6109.2006.00221.x

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.